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Somatic hypermutation of immunoglobulin genes is initiated by activation-induced cytidine deaminase (AID; reference [@bib1]). Most experimental evidences suggest that AID initiates this process by deaminating cytidines into uracils in DNA ([@bib2]). Accordingly, overexpression of AID in fibroblasts is sufficient to induce a G/C-targeted mutagenesis on a highly transcribed reporter gene ([@bib3]). This mutagenesis is supposed to occur by saturation of the repair capacity of the cell, generating transition mutations by replication over the uracils created by deamination. Transversion mutations are likely generated by one or several translesional polymerases that ensure the replication bypass of abasic sites that failed to be corrected by the classical base excision repair pathway after excision of uracils by uracil glycosylases.

In contrast with this "passive" mutagenic process, hypermutation in activated B cells generates mutations at all four bases at the Ig locus ([@bib4]). This mutagenesis is entirely dependent on the initial handling of the lesion by only two pathways, one dependent on the uracil glycosylase UNG, the other one upon a subset of the mismatch repair complex, its DNA binding moiety MSH2--MSH6, together with exonuclease 1 (Exo1; references [@bib5]--[@bib13]). The UNG pathway appears necessary for generating most transversion mutations at G/C bases, whereas the MSH2--MSH6 pathway is required for a large part of the mutagenesis at A/T positions.

Translesional DNA polymerases are specific enzymes, recruited at replication forks stalled in front of noninstructional DNA lesions, and able to bypass them with various specificities and efficiencies (for review see reference [@bib14]). Moreover, based on in vitro assays, many of them are inherently error prone when copying undamaged DNA, again with various intrinsic misincorporation specificities, which made them prime candidates for the Ig gene mutational process, and several experimental data have indeed documented their involvement. The Ig gene mutation profile of xeroderma pigmentosum variant (XP-V) patients, deficient in DNA polymerase η ([@bib15]), has suggested that this enzyme is a major contributor of the MSH2--MSH6 driven A/T mutagenesis ([@bib16]--[@bib18]). The DNA polymerase ι, which colocalizes with polη at replication foci ([@bib19]), has been implied in the Ig gene mutagenesis induced in a Burkitt\'s lymphoma cell line ([@bib20]). However, inactivation of this enzyme in the mouse, by a stop codon present as a natural mutation of various 129 substrains, failed to show any phenotype on hypermutation ([@bib21]). DNA polymerase ζ is proposed to contribute to the overall quantitative efficiency of the process, but not to any specific pathway ([@bib22], [@bib23]).

To look for possible differences in the various DNA polymerases involved between mouse and humans, we inactivated polη in the mouse, and analyzed the Ig mutation pattern in the context of the polι mutation of the 129/Ola strain. This analysis confirms the phenotype observed for polη deficiency in humans, which is not altered further in the presence of the polι mutation of the 129 background.

Results and discussion
======================

Inactivation of the mouse *Polh* gene was performed by a conditional knock-out strategy that introduces loxP sites flanking exon 4, an exon containing the DE polymerase motifs conserved in all Y-family polymerases and indispensable for polη catalytic function ([Fig. 1](#fig1){ref-type="fig"} and references [@bib15], [@bib24]). This strategy was designed with the aim of crossing the animals obtained with mice harboring other DNA repair defects, allowing the follow-up of the B cell lineage in case of lethality of their combined deficiencies. Deletion of exon 4 was performed here in the targeted embryonic stem (ES) cell clone, leaving in place a single loxP site and, therefore, minimizing disturbance around the gene. The *Xpo5* gene, encoding exportin-5 involved in the nuclear export of microRNAs, indeed initiates 200 bp upstream from the first *Polh* exon in opposite transcriptional orientation; affecting expression of this gene is, therefore, likely to result in an early embryonic lethal phenotype ([@bib25]).

![Disruption of the mouse *Polh* gene. (A) Scheme of the mouse *Polh* gene encoding DNA polymerase η. (Closed boxes) coding exons; (open boxes) noncoding regions. (B) Scheme of the gene targeting strategy. Homologous recombination of the gene-targeting construct results in the introduction of loxP sites on both sides of exon 4. (C) Screening of mouse genotypes: deletion of exon 4 is monitored by a PCR around this exon, using primers shown in B. (D) Polη gene expression in control and gene-targeted mice: amplification of polη transcripts is performed using primers in exons 2 and 6, on twofold consecutive dilutions of RT products from total spleen RNA. The amplified product in polη^−/−^ animals corresponds to the splicing of exons 3--5, which generates an out-of-frame sequence.](20050292f1){#fig1}

The heterozygotes obtained by breeding chimeras with C57Bl/6 mice were crossed together and screened for the presence of the stop codon mutation born by the *Poli* gene from the 129/Ola genetic background of the ES cells. Wild-type, homozygous polη-deficient, and double polη-polι mutant mice were selected for analysis. Deletion of exon 4 of polη resulted at the transcriptional level in the direct splicing of exons 3--5, an out-of-frame junction that introduces a stop codon 11 amino acids downstream in exon 5 and generates a truncated polη protein of 102 amino acids ([Fig. 1](#fig1){ref-type="fig"} D). Apart from deletion of exon 4, such a truncated protein would lack domains involved in nuclear localization and repair foci formation ([@bib19]).

Wild-type, polη-deficient, and double polη-polι mutant mice were analyzed for the mutation pattern of their Ig locus. Different types of sequences were analyzed: intronic sequences flanking rearranged J~H~4 sequences ("J~H~4 intronic sequences") and a 560-bp region upstream from the repeats of the Sμ core sequence (hereafter referred to as "pre-switch"), both from Peyer\'s patch PNA^high^ B cells ([Table I](#tbl1){ref-type="table"}).

###### 

Somatic mutations in J~H~4 intronic sequences and Sμ core upstream sequences from normal and mutant mice

  -------------------------------------------------------------------------------------------------------------------------------------------------------
                                              J~H~4 intronic sequence (490 bp)   Sμ core upstream sequence (560 bp)                              
  ------------------------------------------- ---------------------------------- ------------------------------------ -------- -------- -------- --------
  Number of sequences                         21                                 71                                   53       96       122      127

  Total length sequenced (bp)                 10,290                             34,790                               25,970   53,760   66,320   71,120

  Unmutated sequences (%)                     14                                 17                                   25       42       46       57

  Total number of mutations                   124                                241                                  129      147      160      122

  Number of deletions and insertions          2                                  4                                    0        4        3        2

  Mutation frequency per total sequences\     1.2                                0.7                                  0.5      0.3      0.2      0.2
    (per 100 bp)                                                                                                                                 

  Mutation frequency per mutated sequences\   1.4                                0.8                                  0.7      0.5      0.4      0.4
    (per 100 bp)                                                                                                                                 
  -------------------------------------------------------------------------------------------------------------------------------------------------------

No B cell anomalies were observed in either type of polymerase-deficient animals. Ig sequences from polη^−/−^ PNA^high^ B cells displayed the same specific pattern as those obtained from memory B cells of XP-V patients; i.e., a marked reduction of mutations at A/T base pairs: 86.1% mutations at G/C base pairs for the J~H~4 intron and 88.6% for the pre-switch sequence (vs. 89.3 and 89.8% for the corresponding Ig gene sequences in XP-V patients; [Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, [Table II](#tbl2){ref-type="table"}, and reference [@bib17]). Mutation frequencies were somewhat lower for polη-deficient animals compared with wild type when J~H~4 intronic sequences are considered, but similar for the pre-switch sequences. Such a quantitative dissociation has been described for MSH6- and for UNG/MSH2-deficient animals ([@bib5], [@bib13]).

![Distribution of mutations in the V~H~DJ~H~4 flanking sequence ("J~H~4 intronic region") of Peyer\'s patches PNA^high^ B cells from polη- and polη-polι-deficient mice. (A) Pattern of nucleotide substitution in control mice (two animals), polη-deficient mice (three animals), polη- and polι-deficient mice (two animals), and from all mutant animals together. Data are given as percent substitution after correction for base composition (490 bp starting from the exon/intron border: A, 26.3%; C, 14.9%; G, 27.4%; T, 31.4%). (B) Accumulation of mutations in individual J~H~4 intronic sequences. The distribution of sequences harboring a given number of mutations relative to the total number of mutated sequences is represented for the three mouse genotypes.](20050292f2){#fig2}

![Distribution of mutations in the Sμ core upstream region (pre-switch) of Peyer\'s patches PNA^high^ B cells from polη- and polη-polι-deficient mice. (A) Pattern of nucleotide substitution from the same control and mutant animals described in [Fig. 2](#fig2){ref-type="fig"}. Base composition: 560 bp; A, 33.2%; C, 16.4%; G, 27.5%; T, 22.9%. (B) Accumulation of mutations in individual pre-switch sequences. Same representation as in [Fig. 2](#fig2){ref-type="fig"} B. (C) Distribution of mutations along the pre-switch sequence. Mutations from polη-deficient mice are listed above the sequence, and mutations from double-deficient mice are listed below the sequence. "G" within R[G]{.ul}YW motifs and "C" within WR[C]{.ul}Y motifs are underlined.](20050292f3){#fig3}

###### 

Pattern of nucleotide changes in J~H~4 intronic sequences of normal, polη-, and MSH2-deficient mice

                                                                         Within G/C   Within A/T                        
  ---------------------------------------------- ----------- ----------- ------------ ------------ ------ ------ ------ ------
  Mouse                                                                                                                 
  Controls 1[a](#tfn1){ref-type="table-fn"}      44.3:55.7   53.7:46.3   61.4         18.5         20.1   47.6   26.2   26.2
  Controls 1[b](#tfn2){ref-type="table-fn"}      49.9:50.1   53.3:46.7   54.5         16.8         28.7   52.1   25.9   22.0
  *Pol*η^−/−^ [c](#tfn3){ref-type="table-fn"}    85.5:14.5   51.3:48.7   57.1         12.7         30.2   17.2   26.2   56.2
  *Msh2* ^−/−^ [d](#tfn4){ref-type="table-fn"}   87.0:13.0   71.2:28.8   74.0         14.0         12.0   52.7   25.7   21.6
  Human                                                                                                                 
  Controls 1[e](#tfn5){ref-type="table-fn"}      46.0:54.0   51.2:48.8   55.4         16.5         28.1   47.6   25.0   27.4
  *XP-V* [e](#tfn5){ref-type="table-fn"}         89.3:10.7   46.6:53.4   51.1         17.1         31.8   9.4    36.4   54.2

Values in bold represent significant differences from controls discussed in the text.

This study (122 mutations).

From a larger sample (334 mutations; reference [@bib36]).

This study, data from all deficient mice together (366 mutations).

Data from mice deficient in the MSH2-dependent pathway (*Msh2* ^−/−^, *Exo1* ^−/−^, *Msh2* ^G674A^) were pooled (326 mutations obtained by Pfu polymerase; references [@bib8], 11, 12).

From ref. [@bib17] (168 mutations).

We next compared the mutation profile of mice harboring both polη and polι inactivation. These profiles appear extremely similar, either in their distribution along the sequence (shown for the pre-switch sequence in [Fig. 3](#fig3){ref-type="fig"} C), or in their base substitution characteristics ([Figs. 2](#fig2){ref-type="fig"} A and 3 A). The lack of phenotype of polι-deficient mice on Ig gene hypermutation is, therefore, not due to a compensatory role of polη in this specific strain.

All further analyses were, therefore, performed on pooled data from both types of mutant mice, allowing us to compare larger databases (366 mutations for the J~H~4 intron and 277 for the pre-switch sequence). The targeting was slightly more pronounced for C than for G, in particular for the pre-switch sequence. Such an increase has been described in switch junctions from XP-V patients ([@bib18]). However, among the three types of sequences that we have analyzed in similar patients, we could not observe this bias in either switch junctions or J~H~4 introns, the specific increase in C mutations being only significant in pre-switch sequences from XP-V individuals ([@bib17]). The general relevance of this observation is, therefore, difficult to assess at this stage. Moreover, among G/C mutations, no difference from wild type is noticeable in the relative proportion of transitions and transversions ([Table II](#tbl2){ref-type="table"}).

MSH2 deficiency, together with defects in MSH6 and Exo1, results in a similar bias toward G/C mutagenesis ([@bib7]--[@bib13]). We, therefore, wanted to compare the mutation pattern in the J~H~4 intronic sequence between *Msh2* ^−^ *^/^* ^−^ and *Polh* ^−^ *^/^* ^−^ animals. This pattern was established using data from both MSH2- and Exo1-deficient animals, as well as MSH2-ATPase mutant mice (326 mutations), taking into account only data obtained using Pfu polymerase, to exclude any contribution of less accurate enzymes whose intrinsic error spectrum might specifically impinge on the A/T pattern. At G/C base pairs, these mutant mice show a strong bias toward transitions, which has been interpreted as an increased replicative bypass of uracils, the absence of the mismatch-binding complex leading to an increased fraction of deaminated bases escaping detection and repair. *Polh* ^−^ *^/^* ^−^ animals, in contrast, show a transition/transversion distribution at G/C bases similar to controls. Strikingly, the mutation pattern at A/T bases pairs shows the reverse situation. MSH2 deficiency shows a distribution similar to wild type, whereas polη deficiency results in a strong transversion bias. This transversion bias is consistent enough to emerge from both types of sequences analyzed (J~H~4 and pre-switch), and in both mouse and human polη deficiencies ([Table II](#tbl2){ref-type="table"}). Moreover, among transversions at A/T bases, most of them are A to C or T to G changes, which represent more than half of all A/T mutations. Such a mutation bias has been described for DNA polymerase κ ([@bib26], [@bib27]). It is thus possible that, in the absence of polη, the mismatch binding complex is able to recruit a different translesional enzyme, which, due to its specific misincorporation pattern, would be less mutagenic at A/T base pairs, leading to a lower frequency of A/T mutations with a specific transversion bias. Because polκ-deficient animals do not harbor the slightest alteration of their A/T mutation pattern ([@bib28]), it is probable that this enzyme is not a normal actor of the Ig gene mutation process, being on duty only in case of absence of the regular partner of the MSH2--MSH6 complex (i.e., polη).

Polμ is another enzyme with such a transversion bias ([@bib29]). However, contrary to polη and polκ, its preferred misincorporation is at copying A, and not T. It is therefore unlikely, in the mouse at least, that polμ could generate the A over T bias of mutations in J~H~4 sequences, present in control mice and conserved in polη-deficient animals.

UNG and MSH2--MSH6 are the only two repair pathways handling uracils generated by AID during Ig gene hypermutation. The model of Neuberger et al. ([@bib5]) posits that G/C mutations are introduced by replication over the uracils or the abasic sites generated by uracil glycosylase, both events occurring on the DNA strand opposed to the lesion and without repair. Replication over the abasic site would involve translesional DNA polymerases in their "classical" role of damage bypass. Effectively, in the AID-dependent mutations observed in the chicken cell line DT40 that are almost entirely restricted to G/C bases, Rev1 has been proposed to be the major enzyme involved ([@bib30]). As the mutation pattern of DT40 is more biased toward G to C and C to G transversions (the hallmark of Rev1) than it is in the mouse, it is so far unclear how many translesional polymerases are involved in the G/C mutation pattern in mouse (and human) B cells. Mutations at A/T bases are more difficult to explain on a strict replication mode within this model.

In another scenario, the MSH2--MSH6 complex would recruit polη for an error-prone repair of the lesion (i.e., on the same DNA strand) that would remove the uracil or the abasic site and create mismatches at nearby A/T bases because this enzyme is inherently more mutagenic at copying Ts. Along this line, specific modifications of AID in hypermutating B cells might also actively recruit UNG at the site of the lesion ([@bib31]), driving the G/C mutagenesis to proceed differently from a strict saturation of the normal repair of uracils. In such a scheme, the dichotomy between translesion bypass and error-prone repair for the G/C versus A/T mutation pathways might have to be reassessed.

The absence of phenotype of the polι mutation of the 129 strains obviously questions the relevance of the polι-dependent mutagenic process that we described in the BL2 Burkitt\'s lymphoma cell line ([@bib20]). In fact, it has been reported that such a polι-dependent mutagenesis can be induced at the Ig locus in B cell lines infected by the hepatitis C virus ([@bib32]). These mutations would be related to the specific metabolic alterations brought upon infection by this oncogenic virus, alterations that may be shared by many B cell lymphomas ([@bib33]). Alternatively, inactivation of polι in the 129/Ola mouse strain might show leakiness, in particular in activated B cells, by either read-trough of the stop codon or alternative splicing. A classical inactivation of the *Poli* gene and the analysis of mice cumulating several deficiencies in the activities involved in hypermutation might contribute to address these issues.

Materials and Methods
=====================

Construction of targeting vectors.
----------------------------------

Three fragments from the POLH locus were amplified and cloned in the pFlox vector ([@bib34]): fragment 1, 5′ flank; fragment 2, exon 4; and fragment 3, 3′ flank. Construction of the targeting vector and screening of recombinant clones are described in supplemental Materials and methods (available at <http://www.jem.org/cgi/content/full/jem.20050292/DC1>). Transfection of E14.1 ES cells was performed as described ([@bib35]). One recombinant clone was obtained out of 287 ES clones, and subjected to Cre-mediated excision to generate exon 4--deleted clones.

Analysis of gene-targeted mice.
-------------------------------

Screening of gene targeted mice was performed by PCR around exon 4 (described in [Fig. 1](#fig1){ref-type="fig"}) using the following primers: 5′-screen, 5′-GTCTCCCCAGATGTATCTCC-3′, and 3′-screen, 5′-GCATTGTACACCTGTGGTCC-3′ (45 s at 94°C, 30 s at 59°C, 3 min at 72°C, 40 cycles with Taq polymerase; Biolabs). The polι mutation of the 129/Ola background was screened by direct sequencing of a 540-bp genomic fragment encompassing exon 2 (amplified by iota-exon 2-5′, 5′-TTAAAGCAGGACTGAAGACC-3′; iota-exon 2-3′, 5′-CACATTTACTCTCGGTTGCA-3′, for 15 s at 98°C, 30 s at 60°C, 15 s at 72°C, 40 cycles with Phusion DNA polymerase; Finnzymes). Polη mRNA expression was analyzed by RT-PCR (Stratascript; Stratagene), using splenic RNA extracted by the QIAGEN RNeasy kit and PCR primers located in exons 2 and 6 (exon 2, 5′-GGGCAGAATCGAGTGGTTGC-3′; exon 6 reverse, 5′-GCGGTTGGGCTTATTTAGTCC-3′, 30 s at 95°C, 90 s at 68°C, 40 cycles with Advantage II polymerase mix; CLONTECH Laboratories, Inc.).

Analysis of mutations in the Ig locus.
--------------------------------------

B220^+^ PNA^high^ B cells from Peyer\'s patches were isolated from 3--4-mo-old animals as described previously ([@bib8]). Amplification of the J~H~4 intronic sequence flanking rearranged V~H~ genes was performed using a mixture of primers amplifying most V~H~ gene families described (compiled from the mouse V gene IMGT database, <http://imgt.cines.fr>): V1-FR3, 5′-GAGGACTCTGCRGTCTATTWCTGTGC-3′; V5-FR3, 5′-GAGGACACRGCCATGTATTACTGTGC-3′; V3-FR3, 5′-GAGGACACACCCACATATTACTGTGC-3′; V7-FR3, 5′-GAGGACAGTGCCACTTATTACTGTGC-3′; and V9-FR3, 5′-ATGAGGACATGGCTACATATTTCTGT-3′, respectively, in a 6:3:1:1:1 ratio, and J~H~3′, 5′-TGAGACCGAGGCTAGATGCC-3′. PCR was performed on five aliquots of 500 or 1,000 cells (15 s 98°C, 30 s 64°C, 30 s 72°C for 50 cycles using Phusion DNA polymerase) and 480 bp sequences were determined using the J~H~3′ primer. A 735-bp fragment upstream from the Sμ core repeat sequence was amplified using primers Sμ-5′, 5′-GTTGAGGTACTGATGCTGTC-3′ and Sμ-3′, 5′-CCAGCCTAGTTTAGCTTAGC-3′ (45 s at 94°C, 30 s at 58°C, 2 min at 72°C, 40 cycles with Pfu Turbo), and a 560-bp sequence was determined using primer 5′-CTATTCTGGCTCTTCTTAAGC-3′. Sequences were obtained with an ABI Prism 3100 Genetic Analyzer after cloning in the Zero Blunt vector (Invitrogen).

Online supplemental material.
-----------------------------

Construction of the targeting vector for inactivation of the *Polh* gene, as well as conditions for analysis of the recombinant ES clones are described online. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20050292/DC1>.
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